What is 950160.KQ's current stock price?

950160.KQ (Kolon TissueGene, Inc.) is currently trading at ₩17,660.00 with a market cap of ₩1.50T.

What sector is Kolon TissueGene, Inc. in?

Kolon TissueGene, Inc. (950160.KQ) operates in the Healthcare sector, specifically in the Biotechnology industry.

InvestLog

Back to Market返回行情

950160.KQ Kolon TissueGene, Inc.

KOEHealthcare

₩17,660+0.51%LatestMarket Cap: ₩1.50T

As of 2026-08-09 03:21

Why 950160.KQ matters now

Kolon TissueGene, Inc. (950160.KQ) is a Korea stock in Healthcare. The latest InvestLog snapshot shows ₩17,660.00 with +0.51% on the session and ₩1.50T in market capitalization.

Valuation context is available even where detailed statement rows are sparse: InvestLog currently shows P/E -5.06, gross margin 13.2%, and operating margin -426.2%.

Valuation

P/E (TTM)

-5.06

PEG

—

P/B

11.79

P/S

283.56

EV/EBITDA

-8.60

DCF Value

—

FCF Yield

-5.6%

Div Yield

0.0%

Margins & Returns

Gross Margin

13.2%

Operating Margin

-426.2%

Net Margin

-5479.6%

ROE

-236.3%

ROA

-56.6%

ROIC

-11.8%

Listing Info

Market

Korea

Exchange

KOE

Currency

KRW

Sector

Healthcare

Industry

Biotechnology

Country

Kolon TissueGene, Inc. is a biopharmaceutical firm specializing in the advancement of clinical-stage cell-based treatments for osteoarthritis. Its flagship offering is TG-C, a proprietary platform technology that integrates allogeneic primary cells with genetically engineered counterparts. Established by Kwan H. Lee on June 9, 1999, the enterprise maintains its corporate headquarters in Rockville, Maryland.